stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Adaptive Biotechnologies CorpADPT
$28.322.48%-0.72

Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp stock is traded at $28.32, with a volume of 142,779. It is down -2.48% in the last 24 hours and up +17.90% over the past month. Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
Previous Close:
$29.04
Open:
$28.26
24h Volume:
142,779
Relative Volume:
0.06
Market Cap:
$4.58B
Revenue:
$295.41M
Net Income/Loss:
-$49.64M
P/E Ratio:
-
EPS:
-$0.3274
Net Cash Flow:
-$29.54M
1W Performance:
-6.41%
1M Performance:
+17.90%
6M Performance:
+120.73%
1Y Performance:
+100.85%
1-Day Range:
$27.51$28.52
1-Week Range:
$27.51$32.21
52-Week Range:
$12.00$32.21

Adaptive Biotechnologies Corp Stock (ADPT) Company Profile

Name
Adaptive Biotechnologies Corp
Phone
206-659-0067
Address
1165 EASTLAKE AVE E, SEATTLE, WA, USA
Employee
624
Next Earnings Date
-
Latest SEC Filings
SEC
ADPT's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Adaptive Biotechnologies Corp Stock (ADPT) Financials Data

Similar to ADPT